“…Furthermore, studies have demonstrated that TNFα, IL-1β, and IFN-γ induce ROS production in multiple types of human cells ( Yang et al, 2007 ; Agharazii et al, 2014 ). Similarly, increased levels of pro-inflammatory factors and oxidative products have been observed in animal POI models induced by chemotherapy drugs or radiotherapy, and antioxidats can simultaneously reduce pro-inflammatory factors (TNF α, IL-6, and IL-10) and oxidative product (malondialdehyde (MDA), H 2 O 2 , and ROS) levels by activating PI3K/AKT/mTOR or inhibiting NF-κB signaling pathways, thereby improving ovarian function ( He et al, 2017 ; Liu C et al, 2018 ; Li and Liu, 2018 ; Jiang et al, 2019 ). In summary, oxidative stress can promote inflammation in the ovaries and cause ovarian aging ( Figure 3 ).…”